Cary J. Claiborne - Nov 2, 2021 Form 3 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ Cary J. Claiborne
Stock symbol
ADIL
Transactions as of
Nov 2, 2021
Transactions value $
$0
Form type
3
Date filed
11/3/2021, 04:34 PM
Next filing
Dec 8, 2021

No securities are beneficially owned.